Early signal detection of adverse events following influenza vaccination using proportional reporting ratio, Victoria, Australia

PLoS One. 2019 Nov 1;14(11):e0224702. doi: 10.1371/journal.pone.0224702. eCollection 2019.

Abstract

Introduction: Timely adverse event following immunisation (AEFI) signal event detection is essential to minimise further vaccinees receiving unsafe vaccines. We explored the proportional reporting ratio (PRR) ability to detect two known signal events with influenza vaccines with the aim of providing a model for prospective routine signal detection and improving vaccine safety surveillance in Australia.

Methods: Passive AEFI surveillance reports from 2008-2017 relating to influenza vaccines were accessed from the Australian SAEFVIC (Victoria) database. Proportional reporting ratios were calculated for two vaccine-event categories; fever and allergic AEFI. Signal detection sensitivity for two known signal events were determined using weekly data; cumulative data by individual year and; cumulative for all previous years. Signal event thresholds of PRR ≥2 and Chi-square ≥4 were applied.

Results: PRR provided sensitive signal detection when calculated cumulatively by individual year or by all previous years. Known signal events were detected 15 and 11 days earlier than traditional methods used at the time of the actual events.

Conclusion: Utilising a single jurisdiction's data, PRR improved vaccine pharmacovigilance and showed the potential to detect important safety signals much earlier than previously. It has potential to maximise immunisation safety in Australia. This study progresses the necessary work to establish national cohesion for passive surveillance signal detection and strengthen routine Australian vaccine pharmacovigilance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Data Interpretation, Statistical
  • Humans
  • Influenza Vaccines / adverse effects*
  • Influenza, Human / prevention & control
  • Male
  • Models, Statistical
  • Population Surveillance
  • Retrospective Studies
  • Victoria / epidemiology

Substances

  • Influenza Vaccines

Grants and funding

SAEFVIC is funded by the Department of Health and Human Services, Victoria. Hazel Clothier receives an Australian Government Research Training Program Scholarship. Authors HC, JL and JB are employees of SAEFVIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.